SCI Abstract

search
Years of life lost in cutaneous squamous cell carcinoma: analysis of a prospective cohort of 1400 patients
Years of life lost in cutaneous squamous cell carcinoma: analysis of a prospective cohort of 1400 patients
Cutaneous squamous cell carcinoma (cSCC) occurs predominantly in older adults. Disease-specific mortality is low, but conv...
Artificial Intelligence in Lung Cancer: From Early Detection to Personalized Therapy
Artificial Intelligence in Lung Cancer: From Early Detection to Personalized Therapy
This review highlights recent advances in the use of artificial intelligence (AI) for lung cancer screening, risk stratifi...
Unveiling the Intricate Dance: Signaling Pathways in Liver Cancer Metabolism and Immunity
Unveiling the Intricate Dance: Signaling Pathways in Liver Cancer Metabolism and Immunity
Hepatocellular carcinoma is a type of cancer with high rates of occurrence and death worldwide. Recently, the marked incre...
Clinical Development of Novel-Novel Multi-Company Combination Therapies in Oncology
Clinical Development of Novel-Novel Multi-Company Combination Therapies in Oncology
Most novel anti-cancer therapies involve combining multiple immuno-oncology and/or targeted drugs. The historical paradigm...
Malignant Fungating Wounds in Advanced Cancer: Pathophysiology, Odor Control, and Dignity-Centered Management
Malignant Fungating Wounds in Advanced Cancer: Pathophysiology, Odor Control, and Dignity-Centered Management
Malignant fungating wounds (MFWs) represent a profoundly distressing complication of advanced cancer, affecting an estimat...
Mind-Body Therapies for Depression and Anxiety Symptoms in People with Cancer: A Systematic Review with Network Meta-Analysis
Mind-Body Therapies for Depression and Anxiety Symptoms in People with Cancer: A Systematic Review with Network Meta-Analysis
Mind-body therapies (MBTs) are promising forms of treatment for depression and anxiety symptoms in people with cancer, how...
Preventive and Therapeutic Interventions for Anticancer Drug-induced Dermatologic Toxicities: a Scoping Review
Preventive and Therapeutic Interventions for Anticancer Drug-induced Dermatologic Toxicities: a Scoping Review
Anticancer drug-induced dermatologic toxicities frequently compromise quality of life and treatment adherence. While diver...
Targeting GD2 with CAR-T Cell Therapy in Neuroblastoma: Updates, Challenges, and Future Perspectives
Targeting GD2 with CAR-T Cell Therapy in Neuroblastoma: Updates, Challenges, and Future Perspectives
High-risk neuroblastoma remains a challenging pediatric cancer, with survival rates lagging despite advances in multimodal...
Advancing Systemic Treatment beyond First Line for Advanced Hepatocellular Carcinoma
Advancing Systemic Treatment beyond First Line for Advanced Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) ranks among the most prevalent solid malignancies worldwide. A substantial proportion of pa...
Microbiome in Gastrointestinal Tumors: Implications in Oncogenesis and Therapeutic Response
Microbiome in Gastrointestinal Tumors: Implications in Oncogenesis and Therapeutic Response
To provide an updated overview of the role of the human microbiome in the initiation, progression, and therapeutic respons...
Plant-Derived Diterpenoids as Potential Chemotherapeutics for Gastric Cancer
Plant-Derived Diterpenoids as Potential Chemotherapeutics for Gastric Cancer
Gastric cancer remains a leading contributor to cancer-related mortality worldwide despite its declining incidence, with p...
PARP Inhibitors as Radiosensitizers: Current Evidence and Future Directions
PARP Inhibitors as Radiosensitizers: Current Evidence and Future Directions
Radiotherapy remains a fundamental pillar of cancer treatment, however its efficacy is still often limited by tumor radior...
Immunological outcomes of a bespoke DNA cancer vaccine in glioblastoma
Immunological outcomes of a bespoke DNA cancer vaccine in glioblastoma
We report the results of a phase 1 clinical trial (NCT04015700) evaluating the safety and immunogenicity of GNOS-PV01, a p...
Targeting cysteinyl leukotriene receptor 1 reprograms tumor-promoting myelopoiesis and overcomes immune checkpoint therapy resistance
Targeting cysteinyl leukotriene receptor 1 reprograms tumor-promoting myelopoiesis and overcomes immune checkpoint therapy resistance
‘Emergency’ myelopoiesis usually occurs to facilitate malignancy progression. Immunosuppressive neutrophils, a...
Coupling dead cell recognition to Fcγ receptors augments anticancer immunity
Coupling dead cell recognition to Fcγ receptors augments anticancer immunity
Type 1 conventional dendritic cells (cDC1s) are key antigen-presenting cells (APCs) for cross-priming of CD8+ T cells agai...
Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases
Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases
Metastatic solid tumors remain the principal cause of cancer mortality worldwide. High tumor burden impairs responses to c...
Copper depletion boosts CNS leukemia therapy by inhibiting nucleotide synthesis through impairment of mitochondrial complex IV activity
Copper depletion boosts CNS leukemia therapy by inhibiting nucleotide synthesis through impairment of mitochondrial complex IV activity
The nutrient-sparse cerebrospinal fluid (CSF) poses a major challenge to spreading cancer cells. Despite this challenge, l...